Invesco S&P US Dividend Aristocrats ESG Index ETF (IUAE)

I called the number and got a recording machine

she is just a puppet. Ghazi AlBouli is the OZ behind the curtain. I told you so, fools. LMOA

Not sure when but sure looks that way with potential to go much higher. Another large dollar volume today, with no news or PRs. Friday was $150k and today $140k which is great for OTC. https://investorshub.advfn.com/stock-market/USOTC/blaqclouds-id-BCDS/stock-price

Super bullish.

Good afternoon everyone. This morning there was a post that said someone on NBC would be reporting on a new treatment for brain cancer. I watched it
but did see anything. Does anyone know if they actually made a report? Thany you. Peace Reg2015

It's scam the canouse

AVAT, you did it! :)

IMCC … I like 👍 the chart 📊🚬🧨

https://x.com/azbikeguy/status/2066557917575422347?s=46&t=1mtQtgXmx35-BlWutjUYiQ

congrats to those who bought from the floor at 0138 when warnings were to do otherwise..
I love these boards for the lessons they pay :)
best in all folks!
VMHG

Dilution today

They’ll be provided 180 days to comply to bring WKSP share price above $1 share price, upon receipt of Nasdaq under $1 share price listing violation. Even after 180 days, Worksport may request an additional 180 days to become compliant by bringing WKSP share price above $1 for 10 consecutive busine

FACT CHECK:


The evidence currently supports that CV Sciences’ PlusCBD oral products may be eligible for use under the CMS Substance Access Beneficiary Engagement Incentive (BEI) program if they meet the program’s THC and product requirements.


However, th

will this be stuck at 10.00 range for the next 6 months?

Definium Therapeutics Announces New Employee Inducement GrantsJune 15, 2026 4:01 PM
Business Wire Definium Therapeutics, Inc. (“Definium” or the “Company”), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to

Verastem Oncology to Host Investor Conference Call and Report Updated Data and Progress Across VS-7375 Oral KRAS G12D (ON/OFF) Inhibitor TARGET-D Clinical ProgramJune 15, 2026 4:01 PM
Business Wire Featuring updated preliminary clinical data across tumor types

You mean 900? It all comes down to how they structure the release. Solid close and advancers beat decliners.

NextNav Announces Redemption of 5.00% Senior Secured Convertible NotesJune 15, 2026 4:02 PM
Business Wire NextNav Inc. (NASDAQ: NN) (“NextNav or the “Company”) a leader in next-generation 3D positioning, navigation, and timing (PNT) solutions, today announced that it has delive

Natural Grocers® Celebrates Father's Day with Limited-Time Deals and Summer Savings, June 19-21, 2026June 15, 2026 4:01 PM
PR Newswire (US) Customers can enjoy special offers, giveaways, and craveable recipes for Father's Day weekend class="legen

Citizens Financial Group Names Chris Emerson Head of Investor RelationsJune 15, 2026 4:05 PM
Business Wire Citizens Financial Group, Inc. [NYSE: CFG] today announced that Chris Emerson has been appointed Head of Investor Relations, effective August 1. Kristin Silberberg, who cu

RED ROBIN GOURMET BURGERS, INC. ANNOUNCES TWO ADDITIONAL REFRANCHISING AGREEMENTSJune 15, 2026 4:05 PM
PR Newswire (US) Red Robin Announces the Sale of 86 Restaurants for $72.5 million to Support "First Choice Plan" class="legendSp

Another paint job in the final seconds of the trading day....

If this was such a legitimate company, this sort of stinky-pink penny-stock manipulation wouldn't be happening all of the time....

Domo Announces First Quarter Fiscal 2027 Financial Results and Provides Strategic Alternatives Process UpdateJune 15, 2026 4:05 PM
Business Wire Board Determines Strategic Transaction Represents Best Path to Maximize Shareholder Value; Advanced Negotiations Underway Regarding a

In QH $7.24

Nice move in our shares today and I don't think it has a damned thing to do with anything company specific, like getting the EA approval.

Maybe at some point in the not-too-distant future that will change and our shares get priced where they should be.